Skip to main content
ENTA logo
ENTA
(NASDAQ)
Enanta Pharmaceuticals, Inc.
$13.14-- (--)
Loading... - Market loading

Enanta Pharmaceuticals (ENTA) Stock Price & Financial Analysis

Enanta Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$12.61 - $13.26
52-Week High$17.15
52-Week Low$4.09
Open$12.66
Volume112.82K
Average Volume (3M)112.82K
Market Cap377.75M
Shares Outstanding28.75M
Price to Sales (P/S)5.57
Price to Book (P/B)2.95
EV/EBITDA-7.19
Revenue (TTM)66.98M
Net Income (TTM)-71.54M
Free Cash Flow (TTM)-18.46M
EPS (TTM)$-2.49
Profit Margin-106.80%
Operating Margin-109.08%
Return on Equity (ROE)-56.51%
Debt to Equity0.70
50-Day MA$13.40
200-Day MA$11.14
52-Week Change143.80%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Enanta Pharmaceuticals

What is the current stock price for ENTA?

As of the latest trading session, ENTA stock trades at $13.14. The 52-week range is $4.09–$17.15, with a day range of $12.61–$13.26.

What is the P/E ratio for ENTA?

The P/E ratio (Price-to-Earnings) for ENTA is shown in the Key Statistics section. This valuation metric helps compare Enanta Pharmaceuticals, Inc. to industry peers.

Does ENTA pay dividends?

Enanta Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ENTA?

Based on 1 analyst, the consensus for ENTA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ENTA?

Enanta Pharmaceuticals's market capitalization is $377.7M, classifying it as a small-cap company. Enanta Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.